top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advance in the Treatment of Pediatric Leukemia
Advance in the Treatment of Pediatric Leukemia
Autore Handgretinger Rupert
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (300 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 5-azacitidine
ABCC4
acute lymphoblastic leukemia
acute myeloid leukemia
acute pancreatitis
ADC
advances
ALL
allogeneic stem cell transplantation
alternative donors
AML
antibody
antibody-drug conjugate
B-ALL
BCL11B
BCP-ALL
bispecific T-cell engager (BiTE)
CD19
CFTR
childhood acute lymphoblastic leukemia
children
chronic myeloid leukemia
CML
conditioning regimen
COVID-19
diagnosis
DUX4
evolution of CAR T cells
Fc-engineering
FDA-approved CAR products
future directions of CAR T cell therapy
genome
hematopoietic stem cell transplantation
IKZF1
immunizations
immunotherapy
juvenile myelomonocytic leukemia
L-asparaginase
leukemia
limitations and complications of CAR T cell therapy
low-risk ALL
lymphoblastic leukemia
minimal residual disease
myelodysplastic/myeloproliferative disorders
n/a
NOTCH1
NUTM1
other extramedullary relapse
PAX5
pediatric
pediatric leukemia
Ph-like
polymorphism
prognosis
RAS signaling
risk-stratified treatment
SNV
T-ALL
targeted therapy
TcR versus CAR
TRAIL
transcriptome
treatment
treatment related toxicity
tyrosine kinase inhibitor
xenograft
ZNF384
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576878903321
Handgretinger Rupert  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Genetic Variants as Targets for Immunotherapy of Hematological Tumors
Genetic Variants as Targets for Immunotherapy of Hematological Tumors
Autore Griffioen Marieke
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 online resource (139 p.)
Soggetto topico Immunology
Medicine and Nursing
Soggetto non controllato allogeneic stem cell transplantation
hematological malignancies
immunotherapy
minor histocompatibility antigens
neoantigens
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557776503321
Griffioen Marieke  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui